ARCHIVES

Federal Coordinating Council On Comparative Effectiveness Research To Hold Meeting

This article is from The Cancer Letter archive.

Vol. 35 No. 14 | April 10, 2009

Download PDF Visit The Full Archive

Related Articles

Tobacco Interests Contribute a Portion Of the $109 Million Raised by Stand Up To Cancer

September 12, 2014

Arimidex Gets Full Approval For HR+ Early Breast Cancer

September 30, 2005

Bush Asks Hammer To Probe FDA Regulation Of Anticancer Drugs

June 17, 1988

BRAF Inhibitor Shrank Tumors In Phase II Genentech Study

November 26, 2010

ABMT Trials Unlikely To show Clean Benefit for Breast Cancer; Data Release Debated

March 12, 1999

Interview with FDA’s Richard Pazdur

October 30, 2009